[1]Patent:EP1950211,2008,A1.Locationinpatent:Page/Pagecolumn60
[1]Patent:EP1950211,2008,A1.Locationinpatent:Page/Pagecolumn56-57
[1]Patent:EP1950211,2008,A1.Locationinpatent:Page/Pagecolumn58-59
[1]Patent:EP1950211,2008,A1.Locationinpatent:Page/Pagecolumn61
[1]Patent:EP1950211,2008,A1.Locationinpatent:Page/Pagecolumn62
Title: E2012-induced cataract and its predictive biomarkers.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20140101
Title: Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators.
Journal: Bioorganic & medicinal chemistry letters 20120415
Title: First and second generation γ-secretase modulators (GSMs) modulate amyloid-β (Aβ) peptide production through different mechanisms.
Journal: The Journal of biological chemistry 20120406
Title: A canine model to evaluate efficacy and safety of γ-secretase inhibitors and modulators.
Journal: Journal of Alzheimer's disease : JAD 20120101
Title: Aminothiazoles as γ-secretase modulators.
Journal: Bioorganic & medicinal chemistry letters 20111101
Title: Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs.
Journal: Journal of Alzheimer's disease : JAD 20100101
Title: Nakano-Ito K, et al. E2012-induced cataract and its predictive biomarkers. Toxicol Sci. 2014 Jan;137(1):249-58.
Title: Portelius E, Van Broeck B, Andreasson U, Gustavsson MK, Mercken M, Zetterberg H, Borghys H, Blennow K.Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs.J Alzheimers Dis. 2010;21(3):1005-12.
